Skip to content
Peptigraph home

IGF-1 LR3 Side Effects: What Studies and Users Report

What FDA labels, clinical studies and people who use IGF-1 LR3 report, how strong that evidence is, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureIGF-1 analogUpdated

Side effects reported in studies

Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.

Side effects of IGF-1 LR3 in labels and published studies
Side effectHow commonStudy typeSource
Lower circulating amino acids (growth-restricted fetal sheep)“Amino acid concentrations decreased in LR3 (baseline vs. final individual means comparison P = 0.0232) but not in VEH (P = 0.3866).”Frequency not statedAnimal · sheep (not a human result)n = 14American journal of physiology. Endocrinology and metabolism 2025, PMID 39679943
Lower plasma insulin (fetal sheep)66% lower during hyperglycemic clampAnimal · sheep (not a human result)n = 10Journal of developmental origins of health and disease 2023, PMID 37114757
Reduced weight gain, food intake and plasma insulin (finisher pigs)“A four-day infusion of Long [R3] IGF-I (LR3IGF-I; 180 micrograms/kg/day) decreased the average daily gain, food intake, and plasma IGFBP-3, IGF-I and insulin concentrations.”Frequency not statedAnimal · pig (not a human result)The Journal of endocrinology 1997, PMID 9488001
Suppressed growth hormone (finisher pigs)mean GH down 23%; GH peak area down 60%Animal · pig (not a human result)The Journal of endocrinology 1997, PMID 9488001
Enlarged adrenals, gut, kidneys and spleen (guinea pigs)“However, the fractional weight of adrenals, gut, kidneys and spleen were significantly increased by LR3IGF-I, but again overall growth was not stimulated.”Frequency not statedAnimal · guinea pig (not a human result)The Journal of endocrinology 1995, PMID 7561636
Increased tumour growth (rats with mammary tumours)“Tumour growth was increased by the IGFs, especially by LR3-IGF-I, even though these peptides did not promote growth of the adenocarcinoma in cell culture.”Frequency not statedAnimal · rat (not a human result)The Biochemical journal 1994, PMID 8053901
Reduced food intake, blood glucose and insulin (rats with mammary tumours)“Infusion of IGFs alone at either 200 or 500 microgram/day significantly decreased food intakes as well as circulating levels of insulin and glucose, and consequently failed to promote muscle protein accretion in the host.”Frequency not statedAnimal · rat (not a human result)The Biochemical journal 1994, PMID 8053901
Lower muscle protein synthesis and higher muscle protein breakdown (rats with mammary tumours)“Infusion of LR3-IGF-I, and to a lesser extent IGF-I, led to decreased rates of muscle protein synthesis and increased muscle protein breakdown, but each of these measures was closely related to the final tumour burden”Frequency not statedAnimal · rat (not a human result)The Biochemical journal 1994, PMID 8053901

What users report

Anecdotal evidence, 0 of 4

Side effects people describe from their own use of IGF-1 LR3, quoted from 15 Reddit threads we read in r/Peptides, r/moreplatesmoredates, r/PEDs and r/PeptideGuide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.

Side effects people report from using IGF-1 LR3
What people noticedPeople reporting itIn their words
Low blood sugar1“I went slightly hypo the first day I took it” r/moreplatesmoredates, Jun 2026Also taking other compounds
Fat buildup at the injection site1“right at my injection site on the fat of the left side of my belly is abnormally larger and bulging out” r/Peptides, Sep 2025

A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.

What is not known

  • How common each effect is at the doses people use outside of studies.
  • Effects that take longer to appear than the length of the published studies.
  • How IGF-1 LR3 interacts with other medicines and supplements.
  • Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.

When to get medical help

Get urgent care for: trouble breathing, swelling of the face or throat, a widespread rash, severe or lasting stomach pain, fainting, or an injection site that becomes hot, red and spreading.

This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.

What animal studies found when LR3-IGF-I was infused

In rats carrying mammary tumors, LR3-IGF-I and IGF-I increased tumor growth, LR3 the most, although neither promoted growth of that tumor cell line in culture. This is a rat result.[1]

In the same rats, infusions lowered food intake and circulating glucose.[1]

In pigs, a short infusion of LR3IGF-I decreased average daily gain, food intake and plasma IGFBP-3, IGF-I and insulin concentrations.[4]

In fetal sheep, a short infusion cut insulin concentrations during a glucose clamp. This is a sheep fetal model.[3]

In guinea pigs, organ weights rose with LR3IGF-I while overall growth did not.[5]

Product identity and class reviews

A case report on a seized injection vial found a His-tagged form of the protein, and states that effects in humans are not described.[8]

Common questions

What are the side effects of IGF-1 LR3?

Studies we summarise reported lower circulating amino acids (growth-restricted fetal sheep), lower plasma insulin (fetal sheep), reduced weight gain, food intake and plasma insulin (finisher pigs). The table on this page gives how often each happened and links each source.

What side effects do people who use IGF-1 LR3 report?

In the 15 Reddit threads we read (11 Oct 2026), people most often described low blood sugar (1 person), fat buildup at the injection site (1 person). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.

Is IGF-1 LR3 safe?

No human study of LR3 is in the cached literature, and animal studies report tumor growth, suppressed insulin and changes in organ weights.[1]

Is IGF-1 LR3 banned in sport?

Yes. Prohibited by WADA (S2.3). Tested athletes should not use it.

What are the risks of IGF-1 LR3?

A recent review of GH-axis peptides names dysglycaemia, fluid retention and plausible but unproven mitogenic concerns as class issues.[9]

More on IGF-1 LR3

Sources

  1. 1Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
  2. 2IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
  3. 3Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets.Journal of developmental origins of health and disease · 2023PMID 37114757Accessed 2 Oct 2026
  4. 4Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
  5. 5Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig.The Journal of endocrinology · 1995PMID 7561636Accessed 2 Oct 2026
  6. 6Reddit thread in r/moreplatesmoredates (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  7. 7Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  8. 8Detection of His-tagged Long-R³-IGF-I in a black market product.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2010PMID 20675162Accessed 2 Oct 2026
  9. 9The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026

Found an error? Report a correction.